Dr. Gyawali is an associate professor of Medical Oncology and Public Health Sciences at Queen’s University, Kingston, Canada. During his time at Queen’s University he has given numerous lectures regarding global oncology, cancer policy and critical appraisal.
In addition, he instructs, and has developed the curriculum for the undergraduate course GLPH 488 – Global Oncology: Cancer Care, Policy, Research and Education for the Bachelor of Health Sciences program at Queen’s University. This is the world’s first undergraduate course on Global Oncology.
The course was designed to offer insight into the world of cancer policy and global oncology. Aspects of cancer policy covered include clinical trial designs, surrogate endpoints, appraisal of clinical benefit from cancer drugs, regulatory approval, cost and value of cancer drugs, financial toxicity, disparities in access to cancer treatments, conflicts of interest, real-world evidence and ethical issues in cancer research. Aspects of global oncology covered include global burden of cancer, global disparities in access to cancer care, access to cancer medications worldwide, cancer research and trial infrastructure in low-and-middle-income countries, ethical cancer clinical trials for global oncology, use of technology to address global cancer disparities and finally, the concept of the “cancer groundshot”.
The next offering of GLPH 488 will take place in the Winter 2026 semester.
Past Lectures:
May 2024 – Common Sense Oncology. Queen’s Cancer Research Institute Retreat.
November 2022 – Patient and Public Awareness of Cancer Biology, Trials, and Approval Decisions. Primary coordinator of the event, and Panelist.
November 2022 – The Next 25: Future of Cancer Research at Queen’s. A roundtable discussion with Dr. Jane Philpott of Queen’s University Kingston Canada.
October 2022 – Common Sense in Oncology. Combined Medicine -Oncology Grand Rounds.
June 2021 – How to critically appraise clinical trials? Academic Half Day for Oncology Residents, Queen’s University, Canada
January 2021 – Hijacking of Evidence-Based Medicine: Lessons from Oncology. Public Health Sciences Seminar Series, Queen’s University, Canada
May 2020 – What is Cancer Groundshot? Academic Half-Day Lecture to Med Onc and Rad Onc residents, Queen’s University.
April 2020 – Financial Toxicity of Cancer Treatment. Academic Half-Day Lecture to Med Onc and Rad Onc residents, Queen’s University
January 2020 – Clinical Trials: what, why, how, pitfalls and solutions. Lecture to the patients, families and advocates in Kingston, organized by CCSEO and Colon Cancer.
2019 – Why regulatory approval doesn’t necessarily lead to improved patient outcomes? Fall lecture series, Department of Public Health, Queen’s University.
2019 – Cancer Drug Development: From Regulatory Approval to Improving Patient Outcomes. PATH 822 Course on Experimental Cancer Therapeutics, Queen’s University
2017 to 2018 – Introduction to critical appraisal of medical literature. Weekly 1 hour teaching program at Civil Service Hospital, Kathmandu, Nepal
2013 to 2017 – Treatment overview of major cancers. Weekly 30 min teaching program to Nursing and Pharmacy staff at Nagoya University Hospital, Department of Clinical Oncology, Japan
Dr. Bishal Gyawali 